Silver Book Fact

AFib prevalence projected to double by 2050

By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.

Go A, Hylek E, Phillips K, Chang Y, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18): 2370-5. http://jama.ama-assn.org/content/285/18/2370.abstract

Reference

Title
Prevalence of Diagnosed Atrial Fibrillation in Adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Publication
JAMA
Publication Date
2001
Authors
Go A, Hylek E, Phillips K, Chang Y, et al.
Volume & Issue
Volume 285, Issue 18
Pages
2370-5
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • AFib prevalence estimates
    Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.  
  • AFib, an economic burden
    AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study…  
  • Hospital costs for ischemic stroke
    Hospital costs for nonrecurrent ischemic stroke are 20% higher in patients with atrial fibrillation, than in patients without the disease.  
  • Quality of life in AFib patients
    Individuals with AFib report substantially worse quality of life compared to those without the disease  
  • Median age AFib patient
    The median age of people with atrial fibrillation is about 75 years.